Consequently, you could experience rapid weight loss
October 2023: A Significant Shift in FAA Policy In September and October 2023, the FAA introduced major changes that streamlined medical certification protocol and expanded eligibility for certain weight loss medications, including GLP-1 receptor agonists such as: Semaglutide (Wegovy) Liraglutide (Saxenda) Tirzepatide (Zepbound, Mounjaro) Rather than issuing blanket prohibitions, the FAA established specific pathways for certification (including a fast-track), observation periods, documentation requirements and ongoing monitoring
This formulation is designed for optimal compatibility, absorption and gentle delivery, making it a trusted choice for practitioners nationwide
For GLP-1 users, it's a problem
We currently have GHRP-2 (5mg x 10), Ipamorelin (5mg x 10) for sale and it is in stock and ready for immediate shipping
So, dont lose hope if you dont see immediate results